Serum follicle-stimulating hormone levels predict time to development of castration-resistant prostate cancer

INTRODUCTION: Treatment of advancing prostate cancer focuses on blocking the activation of the androgen receptor with resultant prolonged perturbation of the hypothalamic-pituitary-gonadal axis. Androgen deprivation therapy (ADT) is marked, however, by eventual progression to castration- resistant p...

Full description

Saved in:
Bibliographic Details
Published in:Can Urol Assoc J
Main Authors: Hoare, Dylan, Skinner, Thomas A.A., Black, Angela, Robert Siemens, D.
Format: Artigo
Language:Inglês
Published: Canadian Medical Association 2015
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4455620/
https://ncbi.nlm.nih.gov/pubmed/26085869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.2545
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items